References
- World Health Organization (WHO), Preterm birth Fact sheet N°363 Updated November 2015. Available from: http://www.who.int/mediacentre/factsheets/fs363/en/
- March of Dimes, 2015 Premature Birth Report Cards. Available from: http://www.marchofdimes.org/mission/prematurity-reportcard.aspx
- Romero R, Mazor M, Munoz H, et al. The preterm labor syndrome. Ann N Y Acad Sci 1994;734:414–29
- Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;15345:760–5
- Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379–85
- Da Fonseca EB, Bittar RE, Carvalho MH, et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419–24
- Spong CY, Meis PJ, Thom EA, et al. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery. Am J Obstet Gynecol 2005;193:1127–31
- Romero R, Nicolaides KH, Conde-Agudelo A, et al. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol 2016;48:308–17
- Suhag A, Saccone G, Berghella V. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol 2015;213:479–87
- Saccone G, Suhag A, Berghella V. 17-alpha-hydroxyprogesterone caproate for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol 2015;213:16–22
- Martinez de Tejada B, Karolinski A, 4P trial group, et al. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. BJOG 2015;122:80–91
- Palacio M, Cobo T, Antolín E, et al. PROMISE Collaborative Group. Vaginal progesterone as maintenance treatment after an episode of preterm labor (PROMISE) study: a multicentre, double-blind, randomized, placebo-controlled trial. BJOG 2016;123:1990–9
- Kurjak A. Preterm birth–prediction, prevention, and consequences: an unmet challenge to perinatal medicine, science, and society: the declaration of Dubrovnik. J Matern Fetal Neonatal Med 2010;23:1286–7
- Shay KP, Moreau RF, Smith EJ, et al. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009;1790:1149–60
- Salinthone S, Yadav V, Schillace RV, et al. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS One 2010;5:e13058
- Li G, Fu J, Zhao Y, et al. Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-κB) signaling pathway. Inflammation 2015;38:510–19
- Allport VC, Pieber D, Slater DM, et al. Human labor is associated with nuclear factor-kappaB activity which mediates cyclooxygenase-2 expression and is involved with the ‘functional progesterone withdrawal’. Mol Hum Reprod 2001;7:581–6
- Grandi G, Mueller M, Bersinger N, et al. Progestin suppressed inflammation and cell viability of tumor necrosis factor-α stimulated endometriotic stromal cells. Am J Reprod Immunol 2016;76:292–8
- Hye-Soon K, Hye-Jin K, Keun-Gyu P, et al. α-Lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-κB transcriptional activity. Exp Mol Med 2007;39:106–13
- Ferrand PE, Parry S, Sammel M, et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002;8:494–501
- Moore RM, Novak JB, Kumar D, et al. Alpha-lipoic acid inhibits tumor necrosis factor-induced remodeling and weakening of human fetal membranes. Biol Reprod 2009;80:781–7
- Porcaro G, Brillo E, Giardina I, et al. Alpha lipoic acid (ALA) effects on subchorionic hematoma: preliminary clinical results. Eur Rev Med Pharmacol Sci 2015;19:3426–32
- Costantino M, Guaraldi C, Costantino D. Resolution of subchorionic hematoma and symptoms of threatened miscarriage using vaginal alpha lipoic acid or progesterone: clinical evidences. Eur Rev Med Pharmacol Sci 2016;20:1656–63
- MacIntyre DA, Sykes L, Teoh TG, Bennett PR. Prevention of preterm labor via the modulation of inflammatory pathways. J Matern Fetal Neonatal Med 2012;25:17–20
- Society for Maternal-Fetal Medicine (SMFM). McIntosh J, Feltovich H, Berghella V, et al. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention. Am J Obstet Gynecol 2016;215:B2–7
- Facchinetti F, Paganelli S, Comitini G, et al. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 2007;196:453.e1–4
- Lyell DJ, Pullen KM, Mannan J, et al. Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial. Obstet Gynecol 2008;112:1221–6
- Valenzuela GJ, Sanchez-Ramos L, Romero R, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000;182:1184–90
- Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol 2010;116:393–401
- Monastra G, De Grazia S, Cilaker Micili S, et al. Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in preventing miscarriage. Expert Opin Drug Deliv 2016. [Epub ahead of print]. doi: http://dx.doi.org/10.1080/17425247.2016.1200556
- Makhseed M, Raghupathy R, Azizieh F, et al. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001;16:2219–26
- Harmon QE, Engel SM, Olshan AF, et al. Association of polymorphisms in natural killer cell-related genes with preterm birth. Am J Epidemiol 2013;178:1208–18
- Heinzmann A, Mailaparambil B, Mingirulli N, et al. Association of interleukin-13/-4 and toll-like receptor 10 with preterm births. Neonatology 2009;96:175–81
- van Baaren GJ, Vis JY, Wilms FF, et al. Predictive value of cervical length measurement and fibronectin testing in threatened preterm labor. Obstet Gynecol 2014;123:1185–92
- DeFranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol 2013;208:233e1–6
- Silva SV, Damião R, Fonseca EB, et al. Reference ranges for cervical length by transvaginal scan in singleton pregnancies. J Matern Fetal Neonatal Med 2010;23:379–82
- Gorąca A, Huk-Kolega H, Piechota A, et al. Lipoic acid – biological activity and therapeutic potential. Pharmacol Rep 2011;63:849–58